碧瑤綠色(01397.HK)料下半年收入維持上半年增速 手頭合約創新高
碧瑤綠色(01397.HK)策略及投資總監周榆桐預計,下半年集團收入維持上半年增速。截至10月5日,集團手頭合約增至約47.4億元,創集團歷史新高。
他指,目前集團的生物科技工廠處理全港約三分之一的雞糞,目標未來處理全港所有雞糞。另外,他指,香港現時廚餘為每天3,400噸,而香港現時及新建設施每天可處理600噸,因此集團正探討透過相關技術處理廚餘的市場機遇。
周榆桐提到,政府將於明年4月推出都市固體廢物收費計劃,並預計於2年內推出塑膠飲料容器生產者責任計劃,相信在政策推動下,回收市場將在3年內增長2至3倍,並成為集團增長動力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.